Quest Diagnostics Aktie
WKN: 904533 / ISIN: US74834L1008
|
21.04.2026 12:52:56
|
Quest Diagnostics Profit Advances In Q1
(RTTNews) - Quest Diagnostics (DGX) announced earnings for its first quarter that Increases, from last year
The company's bottom line totaled $252 million, or $2.24 per share. This compares with $220 million, or $1.94 per share, last year.
Excluding items, Quest Diagnostics reported adjusted earnings of $281 million or $2.50 per share for the period.
The company's revenue for the period rose 9.1% to $2.89 billion from $2.65 billion last year.
Quest Diagnostics earnings at a glance (GAAP) :
-Earnings: $252 Mln. vs. $220 Mln. last year. -EPS: $2.24 vs. $1.94 last year. -Revenue: $2.89 Bln vs. $2.65 Bln last year.
-Guidance: Full year EPS guidance: $ 10.63 To $ 10.83 Full year revenue guidance: $ 11.78 B To $ 11.90 B
Der finanzen.at Ratgeber für Aktien!
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Quest Diagnostics Inc.
Analysen zu Quest Diagnostics Inc.
Aktien in diesem Artikel
| Quest Diagnostics Inc. | 173,50 | 0,00% |
|